Filana Therapeutics (FLNA) EBT Margin (2010 - 2026)
Filana Therapeutics (FLNA) posted EBT Margin of 93.68% for Q4 2013, up 166.45 percentage points from -72.77% a year earlier and up 132.59 percentage points from the prior quarter.
Filana Therapeutics (FLNA) EBT Margin (2010 - 2026) Analysis & Trends
For FY2013, Filana Therapeutics' EBT Margin came in at 76.54%, up 108.18 percentage points from FY2012.
- Annual EBT Margin shows a four-year change of +100.74 percentage points (FY2009 to FY2013).
- In prior years, Filana Therapeutics' EBT Margin was -31.64% in FY2012 (-8.89 pp), -22.75% in FY2011 (+48.77 pp), -71.53% in FY2010 (-47.32 pp) and -24.20% in FY2009.
- The Q4 2013 figure stands as the highest quarterly EBT Margin in data going back to Q2 2010.
- On a year-over-year basis, EBT Margin increased in four of the last eight quarters, with an average year-over-year change of +15.11 percentage points.
- The strongest year-over-year quarter for EBT Margin in the past five years was Q4 2013, with a gain of 166.45 percentage points; the weakest was Q4 2012, with a drop of 58.54 percentage points.
- According to Business Quant data, EBT Margin for the three prior quarters was -38.92% (Q3 2013), -15.36% (Q2 2013) and -20.84% (Q1 2013).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 40.25% |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 26.66% |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 25.18% |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | -4.11% |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 29.63% |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 18.19% |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 27.53% |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -131.41% |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | -4.34% |
| 10 | Filana Therapeutics | 32.11 Mn | -338.73 Mn | - | -1,257.43% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1,257.43% |
| Mar 31, 2026 | -1,415.46% |
| Dec 31, 2025 | -1,391.38% |
| Sep 30, 2025 | -1,016.28% |
| Jun 30, 2025 | -3,739.04% |
| Mar 31, 2025 | -1,943.56% |
| Dec 31, 2024 | -1,638.17% |
| Sep 30, 2024 | -1,169.71% |
| Jun 30, 2024 | -2,651.21% |
| Mar 31, 2024 | -1,122.41% |
| Dec 31, 2023 | -1,443.26% |
| Sep 30, 2023 | -1,390.47% |
| Jun 30, 2023 | -1,209.24% |
| Mar 31, 2023 | -1,192.64% |
| Dec 31, 2022 | -1,247.30% |
| Sep 30, 2022 | -2,331.09% |
| Dec 31, 2013 | 93.68% |
| Sep 30, 2013 | -38.92% |
| Jun 30, 2013 | -15.36% |
| Mar 31, 2013 | -20.84% |
Filana Therapeutics EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=FLNA&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "FLNA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=FLNA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();